Boston Neuro Research is committed to understanding and treating depression, a mood disorder that affects how people feel, think, and handle daily activities.

INCLUSIONS:

Participants eligible for the depression study must meet the following criteria:

1. Diagnosis: Individuals must have a clinical diagnosis of major depressive disorder.
2. Age: Participants should be aged 18 to 65 years.
3. Health Status: Stable medical conditions unrelated to depression that do not interfere with study procedures.
4. Informed Consent: Participants must provide informed consent to join the study.

EXCLUSIONS:

Factors that may disqualify individuals from the depression study include:

1. Severe Psychiatric Disorders: Presence of severe psychiatric conditions other than depression, such as bipolar disorder or schizophrenia.
2. Unstable Medical Conditions: Uncontrolled chronic illnesses such as severe cardiovascular disease.
3. Recent Participation: Involvement in other clinical trials within the past 30 days.
4. Substance Abuse: Active substance abuse that could interfere with the study.

MEDICATIONS:

Participants will be treated with specific medications and therapies including:

1. Antidepressants: Medications such as SSRIs and SNRIs.
2. Investigational Drugs: New treatments being tested for efficacy and safety.
3. Adjunct Therapies: Additional treatments such as psychotherapy and lifestyle interventions.

This study aims to improve the understanding and treatment of depression.